News Daily News NOBLE at 5 Years: New Data Favor CABG for Left Main Disease Todd Neale December 23, 2019
News Daily News EACTS Calls for Independent Left Main CAD Evidence Review, Urges ESC Input Shelley Wood December 20, 2019
Presentation Response by David Taggart, MD, PhD to the EXCEL Statement Presenter: David Taggart December 19, 2019
News Daily News Taggart Rebuts EXCEL Response, Insisting Concerns Over MI and Mortality Remain Michael O'Riordan December 18, 2019
News Features EXCEL Investigators Respond to Data Suppression Claims as Debate Erupts Online Michael O'Riordan December 12, 2019
News Daily News EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up Michael O'Riordan December 10, 2019
News Features Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too Michael O'Riordan December 09, 2019
News Conference News AHA 2019 ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD Todd Neale November 16, 2019
Presentation Individualizing Revascularization Strategy for Diabetic Patients With Multivessel CAD: FREEDOM October 17, 2019
News Daily News Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients Michael O'Riordan October 17, 2019
News Daily News DAPT Cuts Saphenous Vein Graft Failure After CABG: Meta-analysis Michael O'Riordan October 17, 2019
News Conference News Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials Michael O'Riordan October 07, 2019
News Conference News TCT 2019 Surgical Volume Matters When It Comes to Repair of Primary MR Todd Neale September 28, 2019
News Conference News ESC 2019 TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization L.A. McKeown September 09, 2019
News Conference News ESC 2019 Ten-Year SYNTAXES Results Fix Roles for CABG, PCI in Complex CAD Shelley Wood September 05, 2019
News Conference News ESC 2019 Long-term Secondary Prevention Post-CABG Important Yet Lacking: SWEDEHEART Yael L. Maxwell September 04, 2019
News Conference News ESC 2019 AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD Todd Neale September 02, 2019
News Daily News Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES Michael O'Riordan August 26, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Daily News Best Strategy Questioned for NSTE ACS Patients With Prior CABG Shelley Wood August 05, 2019